|
1
|
Li B, Yang L, Shen J, Wang C and Jiang Z:
The antiproliferative effect of sildenafil on pulmonary artery
smooth muscle cells is mediated via upregulation of
mitogen-activated protein kinase phosphatase-1 and degradation of
extracellular signal-regulated kinase 1/2 phosphorylation. Anesth
Analg. 105:1034–1041. 2007. View Article : Google Scholar
|
|
2
|
Ohata Y, Ogata S, Nakanishi K, et al:
Expression of P2X4R mRNA and protein in rats with hypobaric
hypoxia-induced pulmonary hypertension. Circ J. 75:945–954. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yildiz P: Molecular mechanisms of
pulmonary hypertension. Clin Chim Acta. 403:9–16. 2009. View Article : Google Scholar
|
|
4
|
Can MM, Tanboğa IH, Demircan HC, et al:
Enhanced hemostatic indices in patients with pulmonary arterial
hypertension: an observational study. Thromb Res. 126:280–282.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Junbao D, Hui Y, Bing W, Jian L, Jianguang
Q and Chaoshu T: Effect of L-arginine on collagen of high
flow-induced pulmonary arterial remodeling. Circ J. 69:603–608.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baber SR, Deng W, Master RG, et al:
Intratracheal mesenchymal stem cell administration attenuates
monocrotaline-induced pulmonary hypertension and endothelial
dysfunction. Am J Physiol Heart Circ Physiol. 292:H1120–H1128.
2007. View Article : Google Scholar
|
|
7
|
Zhao YD, Courtman DW, Ng DS, et al:
Microvascular regeneration in established pulmonary hypertension by
angiogenic gene transfer. Am J Respir Cell Mol Biol. 35:182–189.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun Y, Tian Y, Prabha M, et al: Effects of
sulfur dioxide on hypoxic pulmonary vascular structural remodeling.
Lab Invest. 90:68–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cuifen Z, Lijuan W, Li G, Wei X, Zhiyu W
and Fuhai L: Changes and distributions of peptides derived from
proadrenomedullin in left-to-right shunt pulmonary hypertension of
rats. Circ J. 72:476–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McMurtry MS, Bonnet S, Wu X, et al:
Dichloroacetate prevents and reverses pulmonary hypertension by
inducing pulmonary artery smooth muscle cell apoptosis. Circ Res.
95:830–840. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li M, Dong X, Liu Y, Sun X, Li Z and He J:
Inhibition of ubiquitin proteasome function suppresses
proliferation of pulmonary artery smooth muscle cells. Naunyn
Schmiedebergs Arch Pharmacol. 384:517–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takami Y, Nakagami H, Morishita R, et al:
Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating
enzyme in the vasculature, attenuates NF-kappaB activation.
Arterioscler Thromb Vasc Biol. 27:2184–2190. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma Y, Chen B, Liu D, et al: MG132
treatment attenuates cardiac remodeling and dysfunction following
aortic banding in rats via the NF-κB/TGFβ1 pathway. Biochem
Pharmacol. 81:1228–1236. 2011.PubMed/NCBI
|
|
14
|
Jin UH, Suh SJ, Chang HW, et al:
Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human
aortic smooth muscle cell migration and MMP-9 activity through AKT
signaling pathway. J Cell Biochem. 104:15–26. 2008.
|
|
15
|
Djordjevic T, Hess J, Herkert O, Görlach A
and BelAiba RS: Rac regulates thrombin-induced tissue factor
expression in pulmonary artery smooth muscle cells involving the
nuclear factor-kappaB pathway. Antioxid Redox Signal. 6:713–720.
2004. View Article : Google Scholar
|
|
16
|
Meiners S, Dreger H, Fechner M, et al:
Suppression of cardiomyocyte hypertrophy by inhibition of the
ubiquitin-proteasome system. Hypertension. 51:302–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wrana JL, Attisano L, Wieser R, Ventura F
and Massagué J: Mechanism of activation of the TGF-beta receptor.
Nature. 370:341–347. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Jin HF, Liu D, et al: Hydrogen
sulfide induces apoptosis of pulmonary artery smooth muscle cell in
rats with pulmonary hypertension induced by high pulmonary blood
flow. Chin Med J (Engl). 122:3032–3038. 2009.PubMed/NCBI
|
|
19
|
Luan Y, Zhang ZH, Wei DE, et al:
Implantation of mesenchymal stem cells improves right ventricular
impairments caused by experimental pulmonary hypertension. Am J Med
Sci. 343:402–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YY, Luan Y, Zhang X, et al:
Proteasome inhibitor PS-341 attenuates flow-induced pulmonary
arterial hypertension. Clin Exp Med. June.16–2013.(Epub ahead of
print).
|
|
21
|
Depre C, Wang Q, Yan L, et al: Activation
of the cardiac proteasome during pressure overload promotes
ventricular hypertrophy. Circulation. 114:1821–1818. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naujokat C and Hoffmann S: Role and
function of the 26S proteasome in proliferation and apoptosis. Lab
Invest. 82:965–980. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Doll D, Sarikas A, Krajcik R and Zolk O:
Proteomic expression analysis of cardiomyocytes subjected to
proteasome inhibition. Biochem Biophys Res Commun. 353:436–442.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Voutsadakis IA: Ubiquitination and the
Ubiquitin-Proteasome System as regulators of transcription and
transcription factorsin epithelial mesenchymal transition of
cancer. Tumour Biol. 33:897–910. 2012. View Article : Google Scholar
|
|
25
|
Moore BS, Eustáquio AS and McGlinchey RP:
Advances in and applications of proteasome inhibitors. Curr Opin
Chem Biol. 12:434–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Razeghi P, Baskin KK, Sharma S, et al:
Atrophy, hypertrophy, and hypoxemia induce transcriptional
regulators of the ubiquitin proteasome system in the rat heart.
Biochem Biophys Res Commun. 342:361–364. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meiners S, Laule M, Rother W, et al:
Ubiquitin-proteasome pathway as a new target for the prevention of
restenosis. Circulation. 105:483–489. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barringhaus KG and Matsumura ME: The
proteasome inhibitor lactacystin attenuates growth and migration of
vascular smooth muscle cells and limits the response to arterial
injury. Exp Clin Cardiol. 12:119–124. 2007.PubMed/NCBI
|
|
29
|
Sanchez-Ponce D, Tapia M, Muñoz A and
Garrido JJ: New role of IKK alpha/beta phosphorylated I kappa B
alpha in axon outgrowth and axon initial segment development. Mol
Cell Neurosci. 37:832–844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Farber HW and Loscalzo J: Pulmonary
arterial hypertension. N Engl J Med. 351:1655–1665. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kee K and Naughton MT: Heart failure and
the lung. Circ J. 74:2507–2516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iyer SS, Co C and Rojas M: Mesenchymal
stem cells and inflammatory lung diseases. Panminerva Med. 51:5–16.
2009.PubMed/NCBI
|
|
33
|
Baber SR, Deng W, Master RG, et al:
Intratracheal mesenchymal stem cell administration attenuates
monocrotaline-induced pulmonary hypertension and endothelial
dysfunction. Am J Physiol Heart Circ Physiol. 292:H1120–H1128.
2007. View Article : Google Scholar
|
|
34
|
Patel KM, Crisostomo P, Lahm T, et al:
Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction
by a paracrine mechanism. J Surg Res. 143:281–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Diller GP, van Eijl S, Okonko DO, et al:
Circulating endothelial progenitor cells in patients with
Eisenmenger syndrome and idiopathic pulmonary arterial
hypertension. Circulation. 117:3020–3030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Daroczi B, Kari G, Ren Q, Dicker AP and
Rodeck U: Nuclear factor kappa B inhibitors alleviate and the
proteasome inhibitor PS-341 exacerbates radiation toxicity in
zebrafish embryos. Mol Cancer Ther. 8:2625–2634. 2009. View Article : Google Scholar
|
|
37
|
Zavrski I, Kleeberg L, Kaiser M, et al:
Proteasome as an emerging therapeutic target in cancer. Curr Pharm
Des. 13:471–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Erl W, Hansson GK, de Martin R, Draude G,
Weber KS and Weber C: Nuclear factor-kappa B regulates induction of
apoptosis and inhibitor of apoptosis protein-1 expression in
vascular smooth muscle cells. Circ Res. 84:668–677. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grassia G, Maddaluno M, Musilli C, et al:
The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential
modulator-binding domain peptide for inhibition of injury-induced
neointimal formation. Arterioscler Thromb Vasc Biol. 30:2458–2466.
2010.
|
